skip to Main Content

Extended Release Formulation

Invention relates to an extended release formulation of a broad spectrum macrolide antibiotic such as clarithromycin comprising a unique blend of polymer matrix using two different grades hydroxypropylmethyl cellulose, sodium carbonate and other excepients in an optimized ratio to achieve an extended or delayed drug release profile up to 12 hours without any chemical interaction between drug and excepients.
Status of Patent:Patent Pending in India No. 552/KOL/2010 Click here

Back To Top